Vaxcyte Inc (PCVX)

NASDAQ · Health Care

$62.03 -0.93% Close Oct 30, 2026 Live

Vaxcyte stock today

Vaxcyte closed at $62.03 on October 30, 2026, down 0.93% on the day. Over the past year it returned +38.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $8.96 billion.

$40.00$50.00$60.00$70.00
NovJan 2026MarMayJulSep
Total return with dividends reinvested, to the close on Oct 30, 2026
PeriodPCVXS&P 500 (SPY)
1 month+9.0%-0.9%
3 months+10.8%+2.1%
Year to date+34.4%+11.7%
1 year+38.6%+12.4%
3 years+30.3%+88.5%
5 years+165.1%+76.0%

Key statistics

Market value
$8.96B
52-week range
$40.32 to $73.82
Next report
Nov 3, 2026 (estimated)

About Vaxcyte

Vaxcyte develops recombinant vaccines for infectious diseases.

Sector: Health Care

More on Vaxcyte

No forecast, no recommendation. This page describes Vaxcyte Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.